The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
出版年份 2021 全文链接
标题
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
作者
关键词
-
出版物
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-22
DOI
10.1007/s10741-021-10146-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
- (2021) Michael McDonald et al. CANADIAN JOURNAL OF CARDIOLOGY
- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
- (2020) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction
- (2020) John R. Teerlink et al. JACC-Heart Failure
- Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
- (2020) Michael Boettcher et al. CLINICAL PHARMACOKINETICS
- Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction
- (2020) Frank Kramer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis
- (2020) Alberto Aimo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure
- (2020) Michele Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
- (2020) Muhammad Shahzeb Khan et al. JACC-Heart Failure
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies
- (2019) Alberto Aimo et al. European Journal of Preventive Cardiology
- Rationale and design of the com P ar I son O f sacubitril/valsarta N versus E nalapril on E ffect on nt-p R o-bnp in patients stabilized from an acute H eart F ailure episode (PIONEER-HF) trial
- (2018) Eric J. Velazquez et al. AMERICAN HEART JOURNAL
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator
- (2018) Paul W. Armstrong et al. JACC-Heart Failure
- Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
- (2017) Markus Follmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
- (2015) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction
- (2013) Diana Bonderman et al. CIRCULATION
- Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact
- (2013) John J. V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Nitrate Therapy for Heart Failure
- (2013) Divya Gupta et al. JACC-Heart Failure
- The pathophysiology of heart failure
- (2012) Clinton D. Kemp et al. CARDIOVASCULAR PATHOLOGY
- Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes
- (2012) Mihai Gheorghiade et al. EUROPEAN JOURNAL OF HEART FAILURE
- Network meta-analysis-highly attractive but more methodological research is needed
- (2011) Tianjing Li et al. BMC Medicine
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started